Application Solution

Controlled Release Formulation

Prepare a hydrophilic-matrix development brief before selecting raw HPMC or a formulated blend.

Overview

In a hydrophilic matrix, HPMC can hydrate and form a gel layer. Drug diffusion through the hydrated matrix and polymer erosion can contribute to release; their relative roles depend on the formulation. Define the target release behavior, drug properties and manufacturing route first. This general mechanism is not evidence of JNP product performance or a specified release duration.

Applications

Hydrophilic matrix tablet development
Sustained-release formulation review
Controlled-release development support

Technical Considerations

Record the drug characteristics and target release profile.
Review polymer identity, material attributes and any blend composition.
Establish formulation-specific dissolution, stability and process evaluation; no release duration is guaranteed.
Product availability, composition, documentation and suitability must be confirmed for the proposed supply and intended market. An application relationship is not a substitution or formulation approval.

Questions Before Selection

Can a material page replace dissolution testing?

No. The completed formulation must be evaluated against its own test methods and acceptance criteria.

General Technical References

These sources explain material categories. They are not evidence of JNP product performance, certification or affiliation.

Discuss your pharmaceutical requirements

For B2B sourcing and formulation review, not personal medical advice. Do not submit patient information, confidential formulas or unnecessary sensitive data.